Literature DB >> 32706552

Randomization versus Real-World Evidence. Reply.

Rory Collins1, Louise Bowman1, Martin Landray1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32706552     DOI： 10.1056/NEJMc2020020

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

1.  Identification of threshold for large (dramatic) effects that would obviate randomized trials is not possible.

Authors:  Iztok Hozo; Benjamin Djulbegovic; Austin J Parish; John P A Ioannidis
Journal:  J Clin Epidemiol       Date:  2022-01-25       Impact factor: 7.407

2.  Adverse Events in 1406 Patients Receiving 13,780 Cycles of Azacitidine within the Austrian Registry of Hypomethylating Agents-A Prospective Cohort Study of the AGMT Study-Group.

Authors:  Michael Leisch; Michael Pfeilstöcker; Reinhard Stauder; Sonja Heibl; Heinz Sill; Michael Girschikofsky; Margarete Stampfl-Mattersberger; Christoph Tinchon; Bernd Hartmann; Andreas Petzer; Martin Schreder; David Kiesl; Sonia Vallet; Alexander Egle; Thomas Melchardt; Gudrun Piringer; Armin Zebisch; Sigrid Machherndl-Spandl; Dominik Wolf; Felix Keil; Manuel Drost; Richard Greil; Lisa Pleyer
Journal:  Cancers (Basel)       Date:  2022-05-17       Impact factor: 6.575

Review 3.  Electronic Health Record Network Research in Infectious Diseases.

Authors:  Ravi Jhaveri; Jordan John; Marc Rosenman
Journal:  Clin Ther       Date:  2021-10-08       Impact factor: 3.393
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.